{"url_path":"/sec/raph/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1415397/0001213900-26-056181-index.html","accession_number":"0001213900-26-056181","cik":"0001415397","ticker":"RAPH","issuer_name":"Raphael Pharmaceutical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1415397/0001213900-26-056181-index.html","primary_entity_key":"0001415397","primary_entity_name":"Raphael Pharmaceutical Inc."},"word_count":37,"has_tables":true,"body_markdown":"** **\n\n**Item 1. Legal Proceedings**\n\n \n\nThere have been no material\nchanges to our legal proceedings as described in “Item 3. Legal Proceedings” in our Annual Report on Form 10-K, as filed with\nthe SEC on March 31, 2026."}